Advantage India
Cost
Efficiency
* Low cost of production and R&D boosts efficiency of Indian pharma companies, leading to competitive exports.
* Indian drugs and pharma exports reached US$ 5.78 billion between April 2021- June 2021.

Economic
Drivers
* High economic growth along with increasing penetration of health insurance to push expenditure on healthcare and medicine in India.

policy
Support
* In June 2021, Finance Minister Ms. Nirmala Sitharaman announced an additional outlay of Rs. 197,000 crore (US$ 26,578.3 million) that will be utilised over five years for the pharmaceutical PLI scheme in 13 key sectors such as active pharmaceutical ingredients, drug intermediaries and key starting materials.

Increasing
Investment
* The FDI inflows in the Indian drugs and pharmaceuticals sector reached US$ 1.206 billion between April-December 2021.

Major states for Pharmaceuticals
- Karnataka
- Maharashtra
- Gujarat
- Uttar Pradesh
- Delhi NCR
- Tamil Nadu
- Telangana

IBEF Campaigns
MORE
Experience India - Dubai Expo 2020
From the small towns and districts of India come the big-hearted artists wh...

Geographical Indicators of India
The Geographical Indications Registry is set up for administration of the G...
Case Studies
MOREIBEF BLOG
MOREInvesting in India's Digital Revolution
Introduction The Digital Revolution in India started with the Government o...
India's Progress in Electronic Components & Semiconductor Manufacturing
Introduction The electronics manufacturing industry is one of the fastest-...
India – Global hub of Therapy
Introduction India has one of the oldest healthcare systems in the world, ...